The study is aimed to investigate the different rates of pyloric/ pseudopyloric metaplasia or spasmolytic polypeptide-expressing metaplasia (SPEM) of corpus between autoimmune gastritis and H. pylori-infected non-ulcer dyspepsia.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The pyloric or pseudopyloric metaplasia of corpus by positive TFF2 staining
Timeframe: 1 to 3 months after gastric biopsy
The pyloric or pseudopyloric metaplasia of corpus by H&E staining
Timeframe: 7 days after gastric biopsy